Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate if the study drugs (tranexamic acid or mefenamic
acid) can control irregular bleeding during the first 3 months of using Mirena. The study
drugs tested are tested against placebo ("dummy medication not containing any active drug").
Treatment period is followed by a one-month period when study drugs are not taken but Mirena
use is continued.